Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Advocacy group questions Medanta MD Naresh Trehan's inclusion in panel on pharma marketing practices
The Working Group on Access to Medicines and Treatments has raised concerns over including Dr. Naresh Trehan, chairman and managing director of Medanta, in a committee constituted on the Supreme Court's directions to examine the regulatory…
Wall Street Zen Upgrades NervGen Pharma (NASDAQ:NGEN) to Sell
NervGen Pharma (NASDAQ:NGEN - Get Free Report) was upgraded by research analysts at Wall Street Zen from a 'strong sell' rating to a 'sell' rating in a report issued on Saturday, Wall Street Zen reports. Several other analysts also recently weighed…
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Bumped Down to Sell by Wall Street Zen
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a 'hold' rating to a 'sell' rating in a research note issued to investors on Saturday, Wall Street Zen reports. Several other…
Computer System Validation in Pharma: A Practical Guide to Risk-Based Testing
Software used in pharmaceutical operations does more than automate workflows. It may manage laboratory results, manufacturing records, quality processes, and other data that support regulated activities. When software affects product quality…
NewAmsterdam Pharma (NASDAQ:NAMS) Hits New 12-Month Low - Here's What Happened
Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) hit a new 52-week low during mid-day trading on Saturday. The stock traded as low as $19.13 and last traded at $19.71, with a volume of 2,311,178 shares trading hands. The…
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Stock Has Average Target Price of $36.25 According to Brokerages
Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) have received an average rating of 'Moderate Buy' from the five ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a…
Neuland Laboratories: Betting On New Growth Avenues
The CDMO sub-segment within the pharma sector has proven to be a winner even in the current times of heightened volatility. Earlier this year, we highlighted the positive prospects of Neuland Laboratories, which has transformed into a CDMO-led…
Biotech stocks are surging. How investors can play the new drug innovation boom
Moderna gave investors a scare as its stock plunged on Thursday. But it's still one of the hottest biotechs this year. And it's hardly alone – the sector is on a roll and looks poised for more gains. The iShares Biotechnology ETF (IBB) is up…
Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?
Income seekers and growth investors often choose between biotech pioneers and diversified pharmaceutical giants. Comparing Amgen (AMGN -1.79%) and Johnson & Johnson (JNJ -1.42%) reveals two distinct paths for healthcare investing in 2026. Amgen…
Quebec's best companies to work for were revealed and one got a 95% score from staff
Finding a job is tough. Finding one you like is even tougher. But if seeking new employment in Quebec is one of your goals heading into 2027, a new list might be a good place to start. Great Place to Work has unveiled its 2026 Best Workplaces in…
What is the controversy over the spinal muscular atrophy drug in Keralam? Explained
An initiative launched by Keralam government to make the treatment for Spinal Muscular Atrophy (SMA) accessible to more patients is now courting controversy. SMA is a rare, life-threatening genetic disorder that progressively weakens muscles…
8,009 Shares of Astrazeneca Plc $AZN Purchased by Sowell Financial Services LLC
Sowell Financial Services LLC purchased a new position in Astrazeneca Plc (NYSE:AZN - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 8,009…
Best Pharmaceutical Stocks To Watch Today - October 24th
Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalysts Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck & Co., Inc., Abbott Laboratories, Gilead Sciences, and Pfizer are the seven Pharmaceutical stocks to watch today…
Mutual Funds returns
EQUITY - LARGE & MID CAP FUNDS Bandhan Large & Mid Cap Fund HYBRID - AGGRESSIVE HYBRID FUNDS BOI AXA Mid & Small Cap Eq&Debt EQUITY - SMALL CAP FUNDS Bank of India Small Cap Fund HYBRID - BALANCED ADVANTAGE FUNDS Baroda BNPP Balanced Advantage Fund…
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Stock Rated 'Buy' by Wall Street Analysts
Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) has received an average rating of 'Buy' from the eight analysts that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell…
Receive a Daily briefing on Pharma Industry News
Get Started